Press Releases
-
Oasmia Pharmaceutical Announces Positive Overall Survival Results from Phase III Study of Paclical/Apealea for Treatment of Ovarian Cancer
NEW YORK, NY, UNITED STATES - Apr 27, 2016 - April 27, 2016 -- Oasmia Pharmaceutical AB (OASM), a developer of a new generation of drugs within human and veterinary oncology, today announced positive overall survival results for Paclical/Apealea in the Phase III study that included a total of 789 patients with epithelial ovarian cancer
Apr 27, 2016
-
Montrium Releases eTMF Navigator to Provide Greater Business Intelligence in Clinical Trials
MONTREAL, QC, CANADA - Apr 28, 2016 - Montrium, clinical trial technology specialists, and electronic content management software providers, today, announced the commercial release of the eTMF Navigator, an interactive intelligence dashboard integrated into eTMF Connect
Apr 27, 2016
-
Queen’s University Belfast and Domainex Win Late-Stage Award to Progress Novel Lung Cancer Drug Candidate into the Clinic
BELFAST AND CAMBRIDGE, UK - Apr 26, 2016 - Queens University Belfast and Domainex Ltd. announced today that they have secured a late-stage award from the Wellcome Trust Seeding Drug Discovery scheme to advance therapeutic candidate molecules into clinical evaluation for treatment of non-small cell lung carcinoma (NSCLC)
Apr 26, 2016
-
Bracket Announces New Patient Engagement Tools for eCOA and RTSM Products
WAYNE, PA, UNITED STATES - Apr 20, 2016 - A Bracket, a leading clinical trial specialty services provider, announced platform updates to Bracket eCOATM and Bracket RTSMTM to include native support for SMS messaging with patients and other stakeholders in clinical research programs
Apr 21, 2016
-
Post-Authorization Study Develops Into Crucial Part of Drug Development Design
BERLIN, GERMANY - Apr 20, 2016 - Post-authorization safety studies (PASS) are becoming an integral part of the medicines development. Planning the design of PASS in the early phases of a clinical trial will translate into significant time- and cost-efficiency of pre-approval research
Apr 20, 2016
-
Rho to Highlight Clinical Trial Expertise, Recruit New Team Members During ACRP 2016 Global Conference
CHAPEL HILL, NC - Apr 12, 2016 - Rho, a full-service contract research organization (CRO), is hiring a number of clinical research positions and will be looking to meet potential applicants in the field at the Association of Clinical Research Professionals (ACRP) during the groups 2016 Global Conference, being held April 16-19 in Atlanta, Georgia
Apr 12, 2016
-
Certara Launches the SIVA Toolkit 2.0 to Improve Analysis of In Vitro Drug Development Data
PRINCETON, NJ - Apr 12, 2016 - Certara®, the global biosimulation technology-enabled drug development company, today launched the Simcyp In Vitro (Data) Analysis (SIVA) Toolkit 2
Apr 12, 2016
-
ANT Neuro announces cooperation with MAG & More in high-performance rTMS stimulators.
ENSCHEDE, N/A, THE NETHERLANDS - Apr 6, 2016 - ANT Neuro b.v., part of neuromotion b.v., is pleased to announce its cooperation with MAG & More GmbH in offering high performance, top of the range navigated TMS solutions for the advanced applications in research and clinical care
Apr 5, 2016
-
CSM Announces Promotion of Brian Swites to President
FARGO, ND - Apr 4, 2016 - CSM, a leading clinical trial supply company, today announced the promotion of Brian Swites to President, effective immediately
Apr 1, 2016
-
WIRB-Copernicus Group Establishes WCG Gene Therapy Advisory Board
PRINCETON, NJ - Mar 29, 2016 - WIRB-Copernicus Group® (WCG), one of the world's leading providers of solutions that measurably improve the quality and efficiency of clinical research, today announced that it has assembled a team of world-renowned experts to advise the company regarding the latest advances in gene therapy research
Mar 29, 2016
-
Certara’s Synchrogenix Division Provides Unique Technology Solution, Enabling Biopharma Companies to Comply with EMA Policy 70
PRINCETON, NJ - Mar 24, 2016 - Certara®, the global biosimulation technology-enabled drug development company, today announced that its regulatory and medical consultancy, Synchrogenix, has introduced an artificial intelligence- (AI-) enabled solution to meet the data transparency requirements of the clinical and drug development market
Mar 24, 2016
-
WIRB-Copernicus Group Chief Medical Officer Explores Surgical Innovation Oversight in Academic Surgery Departments
PRINCETON, NJ - Mar 22, 2016 - WIRB-Copernicus Group® (WCG), one of the world's leading providers of solutions that measurably improve the quality and efficiency of clinical research, today announced that the surgical innovation and oversight survey conducted by its Chief Medical Officer and President of Consulting Services Lindsay McNair, MD, MPH, MSB, and co-author Walter L
Mar 22, 2016
-
ERT Recognized with Fourth Consecutive Outstanding Customer Service Award
PHILADELPHIA, PA, UNITED STATES - Mar 21, 2016 - ERT, a leading provider of high-quality patient data collection solutions for use in clinical drug development, today announced it has received Omega Management Group Corp
Mar 21, 2016
-
Joe Martinez to Join Center Point Clinical Services as Chief Executive Officer
MINNETONKA, MN - Mar 17, 2016 - Center Point Clinical Services LLC announced today that it has appointed Joe Martinez as Chief Executive Officer
Mar 17, 2016
-
“The importance of the data does not change” - Interview with Joette Keen, KCR’s Head of Biometrics and Clinical Trial Data Execution Systems (BMX)
, GERMANY - Mar 15, 2016 - Berlin - 15 March 2016 - KCR's Joette Keen talks about her transition to CRO, after spending years in pharma, and how does she see data management role in the ever-changing clinical trials worldx
Mar 15, 2016
-
Clinical Research Services Provider Clintrax Global Joins WIRB-Copernicus Group
PRINCETON, NJ - Mar 9, 2016 - WIRB-Copernicus Group® (WCG), one of the world's leading providers of solutions that measurably improve the quality and efficiency of clinical research, today announced that Clintrax Global has joined its family of companies
Mar 9, 2016
-
Rho Supports Follow-up Study Demonstrating Benefit of Early Peanut Consumption is Maintained Following One Year of Peanut Avoidance
CHAPEL HILL, NC, UNITED STATES - Mar 4, 2016 - Rho, a full-service contract research organization (CRO) focused on bringing new products to market through a full range of product development services, is part of a newly published clinical trial that found that children who consumed peanut-containing foods regularly from infancy to age five and then avoided peanut for one year did not become allergic to peanut
Mar 4, 2016
-
DrugDev and Exostar Collaborate to Streamline and Secure Clinical Trial Process by Linking Exostar Identity Credential with the DrugDev Golden Number
KING OF PRUSSIA PA AND HERNDON VA, PA, UNITED STATES - Mar 2, 2016 - DrugDev and Exostar took a major step today in helping the pharma and CRO industry improve and secure clinical trial master data management as the two companies announced they will combine the power of their unique global identifiers for clinical operations personnel and facilities
Mar 2, 2016
-
WIRB-Copernicus Group Helps Develop Ethics Tool Kit for Clinical Research Protocols; Resulting Product Published in Journal of Medical Ethics
PRINCETON, NJ - Mar 2, 2016 - WIRB-Copernicus Group® (WCG), the world's largest provider of regulatory and ethical review services and software to support clinical research, today announced the publication of an innovative Ethics Tool Kit in the Journal of Medical Ethics
Mar 2, 2016
-
Cypralis Limited Announces Appointment of Dr Michael Peel as Chief Scientific Officer
ONGAR, UNITED KINGDOM - Mar 2, 2016 - Cypralis, a life sciences company focussed on the discovery of novel therapeutics based on modulation of peptidyl-prolyl isomerases (PPIases), has appointed Dr Michael Peel as Chief Scientific Officer
Mar 2, 2016
